This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Cancer
and you are
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how will patients respond to treatment. PURPOSE: This research study is looking at gene and protein expression patterns in predicting response to cetuximab in patients with recurrent and/or metastatic head and neck cancer.

Provided treatments

  • Genetic: DNA and tissue microarray analysis
  • Genetic: reverse transcriptase-polymerase chain reaction
  • Other: mass spectrometry
Tris trial is registered with FDA with number: NCT00898742. The sponsor of the trial is Vanderbilt-Ingram Cancer Center and it is looking for 58 volunteers for the current phase.
Official trial title:
Molecular Signatures of HNSCC in Response to Targeted Therapies